NAT2 Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6993b
Background:
NAT2 is an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens.
Other Names:
Arylamine N-acetyltransferase 2, Arylamide acetylase 2, N-acetyltransferase type 2, NAT-2, Polymorphic arylamine N-acetyltransferase, PNAT, NAT2, AAC2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6993b was selected from the C-term region of human NAT2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: NAT2
Gene ID: 10
Primary Accession: P11245
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
NAT2 is an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens.
Other Names:
Arylamine N-acetyltransferase 2, Arylamide acetylase 2, N-acetyltransferase type 2, NAT-2, Polymorphic arylamine N-acetyltransferase, PNAT, NAT2, AAC2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6993b was selected from the C-term region of human NAT2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: NAT2
Gene ID: 10
Primary Accession: P11245
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review